TORONTO, August 6, 2026, 07:02 EDT
- Celestica sold 9.68 million shares at $310 apiece, generating $3 billion. The share price is 14.5% lower than Wednesday’s closing price.
- The shares were at $311 at 06:55 EDT, falling 14.3% in premarket trading.
- An initial weighted-share estimate indicates a 3.3% to 3.7% reduction to 2026 adjusted EPS, prior to factoring in any gains from the fresh capital.
Shares of Celestica dropped nearly to the offering price ahead of Thursday’s market open. The AI infrastructure vendor set the stock sale price at $310, down from Wednesday’s closing level of $362.76.
The financing totals five times the 2026 free cash flow forecast provided by Celestica. The move will lift the number of shares outstanding by 8.4%, not including the underwriters’ option.
This sets a key benchmark for investors. Investment in inventory and factories needs to exceed dilution before 2027.
| Offering math | Base deal | Full option |
|---|---|---|
| New shares | 9.68 million | 11.13 million |
| Gross proceeds | $3.00 billion | $3.45 billion |
| Share-count increase | 8.4% | 9.7% |
| Existing-holder ownership dilution | 7.8% | 8.8% |
| Proceeds / 2026 free-cash-flow outlook | 5.0 times | 5.75 times |
| Preliminary 2026 adjusted EPS | $10.93 | $10.88 |
Figures are based on 114.98 million shares outstanding and the closing price on August 7. The EPS calculation is based on unadjusted earnings and Celestica’s diluted weighted average shares from the first half.
Celestica’s current adjusted EPS forecast of $11.30 presumes there will be no additional share issuance. If the base agreement proceeds, preliminary figures suggest a dilution impact of 3.3%, rising to 3.7% should the option be taken up. Celestica’s guidance remains unchanged.
The balance sheet sheds light on the timing. Inventory jumped 55% in the first half, and receivables grew by 27%. Capital expenditures surged to over seven times last year’s amount.
| Growth-funding indicator | Latest value | Comparison value | Change |
|---|---|---|---|
| Cash as of June 30 | $535.7 million | $595.6 million at Dec. 31 | -10.1% |
| Accounts receivable | $3.34 billion | $2.64 billion at Dec. 31 | +26.5% |
| Inventory | $3.40 billion | $2.19 billion at Dec. 31 | +55.5% |
| Capital expenditure, first half | $493.3 million | $69.2 million in 2025 | +612.9% |
| Free cash flow, first half | $285.0 million | $213.5 million in 2025 | +33.5% |
Figures from the balance sheet are not audited. Percentage variations are based on Celestica’s filing with the SEC.
The figures are not typical of rescue funding. Celestica held $740 million in term loans and access to $1.74 billion through its revolving credit facility. Opting for equity indicates management is seeking to maintain leverage ahead of a significant production increase.
Mandeep Chawla, Chief Financial Officer, stated the capital would allow Celestica to “seamlessly scale alongside our customers’ evolving multi-year capital deployment plans.” Chief Executive Rob Mionis noted that demand reached a record high for the company. Business Wire
Recent operating figures back up that optimism. Cloud and connectivity revenues increased much more rapidly than Celestica’s other segments. Margins improved as well.
| Operating metric | Latest figure | Comparison |
|---|---|---|
| Second-quarter revenue | $4.70 billion | up 62% from same period last year |
| Connectivity and Cloud Solutions revenue | $3.81 billion | increased 84% |
| Advanced Technology Solutions revenue | $890 million | rose 8% |
| Adjusted operating margin | 8.2% | was 7.4% in prior year |
| Adjusted EPS | $2.54 | $1.39 a year ago |
| 2026 revenue outlook | $20.5 billion | up 65% |
| 2026 adjusted EPS outlook | $11.30 | up 87% |
Celestica released its second-quarter results on July 27. Adjusted results refer to non-GAAP metrics.
Management anticipates the revenue growth rate for 2027 will be higher than 65%. A straightforward calculation using a 65% rate based on the 2026 estimate results in $33.8 billion. The language from management suggests revenue greater than that figure. This calculation is preliminary and does not represent official company guidance.
Following the second-quarter report, analyst targets released stayed significantly higher than $310. These targets were set prior to the equity offering.
| Analyst recommendation | Rating | Target | Upside from $310 | Latest target action |
|---|---|---|---|---|
| Stifel Financial Corp. NYSE:SF | Buy | $500 | 61.3% | Increased from $445 |
| JPMorgan Chase & Co. NYSE:JPM | Overweight | $485 | 56.5% | Lifted from $445 |
| Wolfe Research | Outperform | $475 | 53.2% | Boosted from $425 |
| Royal Bank of Canada NYSE:RY | Outperform | $450 | 45.2% | Up from $440 |
| Barclays PLC NYSE:BCS | Overweight | $430 | 38.7% | Lowered from $441 |
| UBS Group AG NYSE:UBS | Neutral | $410 | 32.3% | Up from $400 |
These recommendations are based on the most recent disclosures by the firms following Celestica’s July earnings announcement. Upside compares to the offering price.
The wide target gap indicates analysts continue to anticipate robust growth. However, UBS’s Neutral stance and Barclays lowering its price target highlight potential valuation constraints. The $310 sale offers investors a more immediate benchmark in the near term.
Cash markets were shut as of the dateline. Celestica rose by 8.6% over the previous week, spanning July 24 to July 31, and climbed an additional 9.4% as of Wednesday. Early Thursday trading indications, however, wiped out the latter increase, putting the stock 6.2% under last Friday’s closing price.
The offering is anticipated to conclude on August 7. In the upcoming week, investors will watch to see if $310 holds as support. Changes to the company’s EPS forecasts would also be significant.
Risks: Program expansions may be subject to delays. Parts availability could become constrained, and limitations on power or water could push back data-center buildouts. Equity funding is provided in advance of demonstrable operating results.
The balance can now be quantified. Current shareholders face short-term dilution in exchange for an increased 2027 earnings base. Achieving this hinges on closing the execution gap.
